Drugs Made In America Acquisition II Corp DMIIU 上一季度的收入表现如何?
Drugs Made In America Acquisition II Corp 的收入预期是多少?
Drugs Made In America Acquisition II Corp 的盈利质量评分是多少?
Drugs Made In America Acquisition II Corp 何时发布财报?
Drugs Made In America Acquisition II Corp 的预期收益是多少?
Drugs Made In America Acquisition II Corp 是否超出收益预期?
关键数据
前收盘价
$10.06
开盘价
$10.04
当日区间
$10.04 - $10.12
52周范围
$9.93 - $10.8
交易量
150
平均成交量
43.3K
每股收益(TTM)
--
股息收益率
--
市值
$658.4M
什么是 DMIIU?
Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to search for business combination targets in the pharmaceutical industry. The firm is neither engaged in any operations nor generated any revenues.